Jeff Yass’s Evommune EVMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$115K Buy
13,920
+736
+6% +$8.83K ﹤0.01% 12445
2026
Q2
$175K Buy
+13,184
New +$306K ﹤0.01% 12072

Other funds holding EVMN

Jeff Yass's EVMN Position: Q3 2026 in Review

Jeff Yass increased its Evommune (EVMN) stake by 5.6% in Q3 2026, buying an estimated $8.83K and bringing the position to 13,920 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #12445.

Jeff Yass first reported a position in EVMN in Q2 2026 and has held it in 2 quarters since. The position peaked at $175K in Q2 2026. 87 funds tracked by Wall St. Rank hold EVMN as of Q3 2026.

  • Jeff Yass held 13,920 shares of Evommune worth $115K as of Q3 2026.
  • Jeff Yass bought 736 Evommune shares in Q3 2026, an estimated $8.83K.
  • Evommune made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12445 holding.
  • Jeff Yass first reported a position in Evommune in Q2 2026 and has held it in 2 quarters since.
  • Jeff Yass's Evommune position peaked at $175K in Q2 2026.
  • 87 funds tracked by Wall St. Rank held Evommune as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.